Recent Statutes, Regulations, and Court Cases Affecting Intellectual Property Rights of Life Sciences Institutions: Key Provisions of the Leahy-Smith America Invents Act and the Biologics Price Competition and Innovation Act; Part III: Analysis of the BPCIA: FDA Guidelines Concerning the Characterization of Reference and Follow-On Macromolecules
Keyword(s):
Keyword(s):
2007 ◽
Vol 6
(4)
◽
pp. 585-610
◽
Keyword(s):
2011 ◽
pp. 1-66
◽